OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials
Ahmadaye Ibrahim Khalil, Li Zhang, Richard Muwonge, et al.
BMJ Open (2023) Vol. 13, Iss. 10, pp. e069616-e069616
Open Access | Times Cited: 18
Ahmadaye Ibrahim Khalil, Li Zhang, Richard Muwonge, et al.
BMJ Open (2023) Vol. 13, Iss. 10, pp. e069616-e069616
Open Access | Times Cited: 18
Showing 18 citing articles:
Human Papillomavirus and Associated Cancers: A Review
JaNiese Elizabeth Jensen, Greta L. Becker, J. Brooks Jackson, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 680-680
Open Access | Times Cited: 24
JaNiese Elizabeth Jensen, Greta L. Becker, J. Brooks Jackson, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 680-680
Open Access | Times Cited: 24
Epidemiology, risk factors, and prevention strategies of HIV, HPV, and other sexually transmitted infections among cisgender and transgender youth: a narrative review
Pierluigi Diana, Susanna Esposito
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 4
Pierluigi Diana, Susanna Esposito
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 4
Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control
Philip E. Castle
Viruses (2024) Vol. 16, Iss. 9, pp. 1357-1357
Open Access | Times Cited: 4
Philip E. Castle
Viruses (2024) Vol. 16, Iss. 9, pp. 1357-1357
Open Access | Times Cited: 4
Human Papillomavirus (HPV) Vaccination: Progress, Challenges, and Future Directions in Global Immunization Strategies
Francesco Branda, Grazia Pavia, Alessandra Ciccozzi, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1293-1293
Open Access | Times Cited: 4
Francesco Branda, Grazia Pavia, Alessandra Ciccozzi, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1293-1293
Open Access | Times Cited: 4
Sexually transmitted human papillomavirus and related sequelae
Wyatt Hanft, Helen C. Stankiewicz Karita, Nikka Khorsandi, et al.
Clinical Microbiology Reviews (2025)
Closed Access
Wyatt Hanft, Helen C. Stankiewicz Karita, Nikka Khorsandi, et al.
Clinical Microbiology Reviews (2025)
Closed Access
Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18–25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT)
Mónica S. Sierra, Loretto Carvajal, Peter Dull, et al.
Vaccine (2025) Vol. 50, pp. 126841-126841
Open Access
Mónica S. Sierra, Loretto Carvajal, Peter Dull, et al.
Vaccine (2025) Vol. 50, pp. 126841-126841
Open Access
Prevention and control of HPV-related cancers in people living with HIV
Anneli Uusküla, Anna Tisler, Jack DeHovitz, et al.
The Lancet HIV (2025)
Closed Access
Anneli Uusküla, Anna Tisler, Jack DeHovitz, et al.
The Lancet HIV (2025)
Closed Access
Viral vector-based therapeutic HPV vaccines
Teng Ji, Yu‐Chuan Liu, Yutong Li, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Teng Ji, Yu‐Chuan Liu, Yutong Li, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report
Pierre‐Stéphane Gsell, Birgitte Giersing, Sami L. Gottlieb, et al.
Vaccine (2023) Vol. 41, Iss. 49, pp. 7307-7312
Closed Access | Times Cited: 5
Pierre‐Stéphane Gsell, Birgitte Giersing, Sami L. Gottlieb, et al.
Vaccine (2023) Vol. 41, Iss. 49, pp. 7307-7312
Closed Access | Times Cited: 5
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer
Peter Dull, Sharon L. Achilles, Rafi Ahmed, et al.
Vaccine (2024) Vol. 42, Iss. 25, pp. 126100-126100
Open Access | Times Cited: 1
Peter Dull, Sharon L. Achilles, Rafi Ahmed, et al.
Vaccine (2024) Vol. 42, Iss. 25, pp. 126100-126100
Open Access | Times Cited: 1
HPV-associated cancers among people living with HIV: nationwide population-based retrospective cohort study 2004–21 in Estonia
Anna Tisler, Karolin Toompere, Marc Bardou, et al.
European Journal of Public Health (2024)
Open Access | Times Cited: 1
Anna Tisler, Karolin Toompere, Marc Bardou, et al.
European Journal of Public Health (2024)
Open Access | Times Cited: 1
The Future of Cervical Cancer Screening
Amelia Goldstein, Mallory Gersh, Gabriela Skovronsky, et al.
International Journal of Women s Health (2024) Vol. Volume 16, pp. 1715-1731
Open Access | Times Cited: 1
Amelia Goldstein, Mallory Gersh, Gabriela Skovronsky, et al.
International Journal of Women s Health (2024) Vol. Volume 16, pp. 1715-1731
Open Access | Times Cited: 1
A cervical cancer control strategy for lower-resource settings: interventions to complement one-dose HPV vaccination
Nicole G. Campos, Douglas R. Lowy, Silvia de Sanjosé, et al.
JNCI Monographs (2024) Vol. 2024, Iss. 67, pp. 417-423
Closed Access
Nicole G. Campos, Douglas R. Lowy, Silvia de Sanjosé, et al.
JNCI Monographs (2024) Vol. 2024, Iss. 67, pp. 417-423
Closed Access
Elimination of human papillomavirus 16-induced tumors by a mucosal rAd5 therapeutic vaccination in a pre-clinical study
Molly R. Braun, Jonathan D. Lindbloom, Anne Moore, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Molly R. Braun, Jonathan D. Lindbloom, Anne Moore, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study
Molly R. Braun, Anne Moore, Jonathan D. Lindbloom, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 955-955
Open Access
Molly R. Braun, Anne Moore, Jonathan D. Lindbloom, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 955-955
Open Access
New Paradigms in Cervical Cancer Prevention
Usha Saraiya
The Journal of Obstetrics and Gynecology of India (2024) Vol. 74, Iss. 4, pp. 295-302
Closed Access
Usha Saraiya
The Journal of Obstetrics and Gynecology of India (2024) Vol. 74, Iss. 4, pp. 295-302
Closed Access
HPV16 mutant E6/E7 construct is protective in mouse model
Maryam Moazami Goodarzi, Ghasem Mosayebi, Ali Ganji, et al.
BMC Biotechnology (2024) Vol. 24, Iss. 1
Open Access
Maryam Moazami Goodarzi, Ghasem Mosayebi, Ali Ganji, et al.
BMC Biotechnology (2024) Vol. 24, Iss. 1
Open Access
Understanding the key determinants of an HPV therapeutic vaccine: a modeling analysis
Jamie A. Cohen, Robyn M. Stuart, Serin Lee, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Jamie A. Cohen, Robyn M. Stuart, Serin Lee, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
